SC 13G/A

SCHEDULE 13G HOLDINGS REPORT AMENDMENT

Company: Viking Therapeutics, Inc.
Filed: February 14, 2020
Accession Number: 0001172661-20-000911

View Document ↗ View on SEC.gov ↗